Osteoarticular infection caused by MDRPseudomonas aeruginosa: the benefits of combination therapy with colistin plus β-lactams | Zendy

Alba Ribera | Zendy; Eva Benavent | Zendy; Jaime Lora-Tamayo | Zendy; Fé Tubau | Zendy; Salvador Pedrero | Zendy; Xavier Cabo | Zendy; Javier Ariza | Zendy; Óscar Murillo | Zendy

Open Access

Osteoarticular infection caused by MDRPseudomonas aeruginosa: the benefits of combination therapy with colistin plus β-lactams

Author(s) -

Alba Ribera,

Eva Benavent,

Jaime Lora-Tamayo,

Fé Tubau,

Salvador Pedrero,

Xavier Cabo,

Javier Ariza,

Óscar Murillo

Publication year - 2015

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkv281

Subject(s) - medicine , colistin , pseudomonas aeruginosa , antibiotics , combination therapy , retrospective cohort study , surgery , microbiology and biotechnology , genetics , bacteria , biology

In the era of emergence of MDR Pseudomonas aeruginosa, osteoarticular infections (OIs) add more difficulties to its treatment. The role of β-lactams (BLs) is questioned and older drugs need to be reconsidered. The objective of this study was to describe our experience in the management of OIs caused by MDR P. aeruginosa and evaluate different therapeutic options.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research